![Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors think so | Fierce Pharma Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors think so | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1554213706/Pumalounging.jpg/Pumalounging.jpg?VersionId=AXzRJpBb66kBzE1ipO.16_8WJAXmXjo2)
Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors think so | Fierce Pharma
Investor Alert: PUMA Capital, LLC was censured and fined $15,000 for failing to implement adequate OTC policies — Stock Fraud Lawyer | Securities Arbitration Attorneys| Furgison Law Group
![Cresset Partners Announces 15-Year Lease With PUMA at 303 Crossroads in Glendale, AZ | Business Wire Cresset Partners Announces 15-Year Lease With PUMA at 303 Crossroads in Glendale, AZ | Business Wire](https://mms.businesswire.com/media/20220629005611/en/1500697/23/Cresset_Partners_-_Orange_-_Horizontal.jpg)